Literature DB >> 15905695

Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation.

Ana Velasco1, Victor Palomar-Asenjo, Laura Gañan, Lluis Catasus, Nuria Llecha, Angel Panizo, Victor Palomar-Garcia, Miquel Quer, Xavier Matias-Guiu.   

Abstract

The familial paraganglioma syndrome is an autosomal dominant disorder characterized by the presence of carotid body paragangliomas and, less frequently, paragangliomas of the glomus jugulare, glomus vagale, and adrenal pheochromocytomas. Germline mutations of the genes for succinate dehydrogenase subunits D, B, or C (SDHD, SDHB, SDHC) have been identified in some kindreds with familial paraganglioma. In this study, we report the clinicopathologic features of four different kindreds with familial paraganglioma, which were screened for germline mutations in the SDHD gene. DNA was obtained from tumor and normal tissue, as well as from peripheral blood. Mutation analysis was performed by single-strand conformation polymorphism analysis and DNA sequencing. SDHD germline mutations were detected in the affected family members of the four families, as well as in several asymptomatic carriers. An identical mutation in exon 4 of SDHD (334-337delACTG) was identified in two apparently unrelated kindreds. The third family showed a germline mutation in exon 2 (W43X). The mutations present in these three families had been previously described in Spanish families, suggesting a founder effect. The fourth family exhibited a mutation in exon 2 of SDHD (170-171delTT), which had not been previously identified. The affected family members of the four kindreds showed paragangliomas, located in the head and neck region, and all of them were benign. These results confirm that genetic testing of SDHD may be a powerful tool for the identification of the syndrome in patients with multiple or bilateral paragangliomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905695     DOI: 10.1097/01.pas.0000158987.07907.7e

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  4 in total

1.  Carney triad, SDH-deficient tumors, and Sdhb+/- mice share abnormal mitochondria.

Authors:  Eva Szarek; Evan R Ball; Alessio Imperiale; Maria Tsokos; Fabio R Faucz; Alessio Giubellino; François-Marie Moussallieh; Izzie-Jacques Namer; Mones S Abu-Asab; Karel Pacak; David Taïeb; J Aidan Carney; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2015-03-25       Impact factor: 5.678

2.  Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.

Authors:  Mariola Peczkowska; Zoran Erlic; Michael M Hoffmann; Mariusz Furmanek; Jaroslaw Cwikla; Agata Kubaszek; Aleksander Prejbisz; Zbigniew Szutkowski; Andrzej Kawecki; Krzysztof Chojnowski; Anna Lewczuk; Mieczyslaw Litwin; Witold Szyfter; Martin A Walter; Maren Sullivan; Charis Eng; Andrzej Januszewicz; Hartmut P H Neumann
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

3.  Familial cervical paragangliomas with lymph node metastasis expressing somatostatin receptor type 2A.

Authors:  Noriko Kimura; Hiroo Tateno; Shigeru Saijo; Akira Horii
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

Review 4.  SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.

Authors:  B Pasini; C A Stratakis
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.